Peptidyl-prolyl isomerase F as a prognostic biomarker associated with immune infiltrates and mitophagy in lung adenocarcinoma
Translational Lung Cancer Research · 2024-06 · 13 (6) · 1346-1364
DOI: 10.21037/tlcr-24-344 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Lung Cancer Research, 2024-06. Verfasst von Zitong Feng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Lung adenocarcinoma (LUAD) is among the most prevalent malignancies worldwide, with unfavorable treatment outcomes. Peptidyl-prolyl isomerase F (PPIF) is known to influence the malignancy traits of tumor progression by modulating the bioenergetics and mitochondrial permeability in cancer cells; however, its role in LUAD remains unclear. Our study seeks to investigate the clinical significance, tumor proliferation, and immune regulatory functions of PPIF in LUAD.
Methods
The expression of PPIF in LUAD tissues and cells was assessed using bioinformatics analysis, immunohistochemistry (IHC), and Western blotting. Survival curve analysis was conducted to examine the prognostic association between PPIF expression and LUAD. The immunomodulatory role of PPIF in LUAD was assessed through the analysis of PPIF expression and immune cell infiltration. A series of gain- and loss-of-function experiments were conducted on PPIF to investigate its biological functions in LUAD both in vitro and in vivo. The mechanisms underlying PPIF's effects on LUAD were delineated through functional enrichment analysis and Western blotting assays.
Results
PPIF exhibited overexpression in LUAD tissues compared to normal controls. Survival curve analysis revealed that patients with LUAD exhibiting higher PPIF expression demonstrated decreased overall survival and a shorter progression-free interval. PPIF was implicated in modulating immune cell infiltration, particularly in regulating the T helper 1-T helper 2 cell balance. Functionally, PPIF was discovered to promote tumor cell proliferation and advance cell-cycle progression. Furthermore, PPIF could impede mitophagy by targeting the FOXO3a/PINK1-Parkin signaling pathway.
Conclusions
The findings of this study indicate that the prognosis-related gene PPIF may have a significant role in the regulation of LUAD cell proliferation, tumor-associated immune cell infiltration, and mitophagy, and thus PPIF may be a promising therapeutic target of LUAD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, China.
- Laboratory of Basic Medical Sciences, Qilu Hospital of Shandong University, Jinan, China.
- Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Laboratory Medicin…
- Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
- Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany.
ORCID-Profile: Zitong Feng, Lin Yuan
Zitieren
APA
Feng, Z., Yuan, L., Ma, L., Yu, W., Kheir, F., Käsmann, L., Brueckl, W. M., Jin, K., Wang, D., Shen, Y., Li, R., & Tian, H. (2024). Peptidyl-prolyl isomerase F as a prognostic biomarker associated with immune infiltrates and mitophagy in lung adenocarcinoma. Translational Lung Cancer Research, 13(6), 1346-1364. https://doi.org/10.21037/tlcr-24-344
Vancouver
Feng Z, Yuan L, Ma L, Yu W, Kheir F, Käsmann L, et al. Peptidyl-prolyl isomerase F as a prognostic biomarker associated with immune infiltrates and mitophagy in lung adenocarcinoma. Translational Lung Cancer Research. 2024;13(6):1346-1364. doi:10.21037/tlcr-24-344
BibTeX
@article{Feng2024,
author = {Feng, Zitong and Yuan, Lin and Ma, Luyuan and Yu, Wenhao and Kheir, Fayez and Käsmann, Lukas and Brueckl, Wolfgang M and Jin, Kai and Wang, Dingxin and Shen, Yi and Li, Rongyang and Tian, Hui},
title = {Peptidyl-prolyl isomerase F as a prognostic biomarker associated with immune infiltrates and mitophagy in lung adenocarcinoma},
journal = {Translational Lung Cancer Research},
year = {2024},
volume = {13},
number = {6},
pages = {1346--1364},
doi = {10.21037/tlcr-24-344}
}
EUVIMED